These totals include tiers that cover only specialty drugs, although the cost-sharing information for the specialty tier is reported separately below
[DOI] [PMC free article] [PubMed] [Google Scholar] 109.Clarke H., Kim D.H., Meza C.A., Ormsbee M.J., Hickner R.C
The defense argues that a gastric emptying test is the only objective and reasonable method of diagnosis, while the plaintiff contends that symptoms alone can serve as the basis for the diagnosis
Applied & Environmental Microbiology, 69 : 74927498
It differs fromPT-141 (Bremelanotide), a modified heptapeptide derivative with MC4R preference, and afamelanotide (Scenesse, FDA 2019), a linear tridecapeptide MC1R selective approved for erythropoietic protoporphyria